Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising.
Symptoms of High Blood Sugar (Hyperglycemia) Causes: Too much food, too little insulin or diabetes pills, illness, or stress. Hyperglycemia, the defining feature of diabetes, is a fundamental cause of vascular target-organ complications, including kidney disease. Diabetes mellitus is the most common cause of kidney failure in the United States4 and is among the most common causes in the rest of the world.
Most of the evidence for this guideline comes from studies of intensive glycemic control in people with type 1 and 2 diabetes and CKD stages 1 and 2 (Table 19 and Table 20).
Observational studies have shown a similar association of poor glycemic control with the development of elevated albuminuria in type 2 diabetes.369-373 Three major intervention studies also have been carried out. For all these studies in both type 1 and type 2 diabetes, the overall numbers of individuals with microalbuminuria who developed macroalbuminuria were small, but less with intensive therapy. A few long-term observational studies have shown that poorer glycemic control is associated with a greater rate of decrease in GFR in patients with type 1 diabetes.374-376 In studies of other interventions, such as ACE inhibitors or ARBs, HbA1c levels often were included as covariates. Most prospective randomized studies used as evidence for the effect of glycemic control on kidney function are limited by the small number of patients reaching an outcome of a decrease in GFR. Several relatively small short-term studies have evaluated whether thiazolidinediones (TZDs) decrease albuminuria more than standard therapy with other oral agents (metformin or sulfonylureas) or dietary treatment for hyperglycemia in patients with type 2 diabetes and microalbuminuria (Table 21).379-382 Albuminuria was decreased or trends in this direction were observed with TZD treatment in all these studies.
This guideline is consistent with the ADA guidelines,34 which recommend that adults with diabetes achieve an HbA1c level less than 7.0% or as close to normal as possible without excessive episodes of hypoglycemia, with the goal of reducing all complications of diabetes.
An overall glycemic goal for people with diabetes of less than 7.0% is very strongly supported by substantial data from large prospective randomized studies of both type 1 and type 2 diabetes.
The major risk for patients attaining HbA1c levels less than 7.0% is the increasing development of hypoglycemia with lower glucose concentrations.
Patients with decreased kidney function (CKD stages 3 to 5) have increased risks for hypoglycemia for 2 reasons: (1) decreased clearance of insulin and some of the oral agents used to treat diabetes, and (2) impaired kidney gluconeogenesis. With progressive decreases in kidney function, decreased clearances of the sulfonylureas or their active metabolites also have been found,385-387 necessitating a decrease in drug dosing to avoid hypoglycemia. An additional factor that may hinder good glycemic control in patients with progressive kidney disease is some degree of inaccuracy of the HbA1c measurement in reflecting ambient glucose concentrations. The patient on long-term dialysis therapy no longer needs to achieve good glycemic control to prevent deterioration of kidney function.
In the opinion of the Work Group, assessment of glycemic control in diabetes and CKD should follow the standards set by the ADA (Table 25).34 In people receiving multiple insulin injections, SMBG is recommended 3 or more times daily (before meals and at bedtime). Other microvascular and macrovascular complications of diabetes are common in those with CKD. Startle easily- Something as simple as the phone ringing will send your heart pounding wildlyFeeling tired all the time- You wake up tired, even after what should have been a good night's sleep.
Intensive treatment of hyperglycemia prevents DKD and may slow the progression of established kidney disease.
A large number of epidemiological studies and controlled trials have defined risk factors for progression of DKD and response to treatment.3 The purpose of this guideline is to review this literature with respect to glycemic control and translate the results into practical strategies for clinicians who treat people with diabetes and CKD, either due to DKD or other causes.
Cumulative Incidence of DKD After 6 Years of Follow-up in Patients with Type 2 Diabetes Treated by Intensive (solid line) and Conventional (dashed line) Insulin Injection Therapy in the Primary-Prevention Cohort of the Kumamoto Study. Cumulative Incidence of DKD After 8 Years of Follow-up in Patients with Type 2 Diabetes Treated by Intensive (solid line) and Conventional (dashed line) Insulin Injection Therapy in the Primary-Prevention Cohort of the Kumamoto Study.
Accordingly, differences in progression rates from microalbuminuria to macroalbuminuria with intensive therapy compared with conventional treatment generally were not statistically significant, although the trends were to reduce progression.

Although the ADA does not have a separate guideline for patients with DKD, it recognizes that certain populations may require special considerations and that less intensive glycemic goals may be indicated in patients with severe or frequent hypoglycemia.
Much of this support stems from benefits for some of the other major complications of diabetes, especially retinopathy.
This is particularly true for those with type 1 diabetes being treated with insulin.132, 138, 384 Although the risk is increased in those with type 2 diabetes being treated with insulin,134, 137 the magnitude of the risk is considerably less.
Table 22 provides recommendations for dosing of drugs used to treat hyperglycemia in patients with CKD stages 3 to 5.
Doses are not specified by level of kidney function, but should be adjusted based on frequent monitoring to balance goals of glycemic control with avoiding hypoglycemia.
Factors that may contribute to falsely decreased values include a reduced red blood cell lifespan, hemolysis, and iron deficiency, whereas falsely increased values may occur due to carbamylation of the hemoglobin and acidosis. However, good control may still prevent or slow the progression of retinopathy, neuropathy, and possibly macrovascular disease. In those receiving less frequent insulin injections, oral agents, or medical nutrition therapy alone, SMBG is useful in achieving glycemic goals. Assessment and management of CVD is addressed in the Background section of these guidelines. Symptoms like those above are frequently discounted when looked at individually, but taken as pieces of the same puzzle, they paint a picture of adrenal glands that need some TLC.
Products and information mentioned herein are not intended to diagnose, treat, cure or prevent any diseases or medical problems.
I have become all too aware that my Endocrine symptoms does not function correctly and my HypoGal system continues to have the domino effect.
Very few studies addressed the benefits and risks of intensive glycemic control in later stages of CKD, let alone in patients who are undergoing dialysis or have received kidney transplants. 132, 368 To assess whether their reduced risk of DKD persisted long term, 1,349 of these subjects were evaluated as part of the EDIC study at the year 7 to 8 post-DCCT visit.133 Data were analyzed according to the original intensive- versus conventional-treatment groups, and the primary-prevention and secondary-intervention cohorts were combined. With respect to kidney outcomes, data are very strong for the development of microalbuminuria.
First-generation sulfonylureas (eg, chlorpropamide, tolazamide, and tolbutamide) generally should be avoided in patients with CKD because these agents rely on the kidney to eliminate both the parent drug and active metabolites, resulting in increased half-lives and risk of hypoglycemia. Other considerations that are not specific to the level of kidney function include avoiding or minimizing the occurrence of interactions with drugs used to lower blood glucose. Postprandial SMBG testing also may be helpful, particularly in patients with gastroparesis, to achieve postprandial glucose goals and in patients using rapid insulin injections before meals to adjust the dose-meal calculation. Screening and treatment of retinopathy and foot care also are essential to the care of patients with diabetes and kidney disease. The inability to cope with stress is, however, not a breakdown of our nerves, but of our adrenal glands, which can burn out after long periods of heightened output. I have also learned that due to the lack and imbalance of cortisol, growth hormone, estrogen and testosterone my body may go into a Hypoglycemia state. The numbers of patients progressing to more advanced outcomes, such as macroalbuminuria and decreases in GFR, are decreased significantly with improved glycemic control, but much of this decrease is related to the smaller number developing microalbuminuria to begin with.
About one third of insulin degradation is carried out by the kidney, and impaired kidney function is associated with a prolonged half-life of insulin. Of the second-generation sulfonylureas (eg, glipizide, gliclazide, glyburide, and glimepiride), glipizide and gliclazide are preferred agents because they do not have active metabolites and do not increase the risk of hypoglycemia in patients with CKD.
The optimal frequency of SMBG has not been established in patients with type 2 diabetes treated by oral agents, but the ADA recommends testing sufficiently often to reach glycemic goals.

In the absence of specific data in the diabetes and CKD population, the Work Group recommends following the standards set by the ADA (Table 26).34 An ophthalmologist or optometrist who is knowledgeable and experienced in the diagnosis and management of diabetic retinopathy should perform a comprehensive dilated eye examination annually in all people with diabetes. Slow to get going, but then pick up some steam until you hit a late afternoon low and need a nap. Hypoglycemia can be life threatening.So what exactly is Hypoglycemia?(1)Hypoglycemia, also called low blood glucose or low blood sugar, occurs when blood glucose drops below normal levels. 137 The UKPDS randomly assigned newly diagnosed patients with type 2 diabetes to intensive management using a sulfonylurea or insulin or to conventional management with diet alone.
Nonetheless, even for those with more advanced disease, evidence supports reaching the recommended HbA1c target. In addition, HbA1c levels should be determined at least twice per year in stable patients who are achieving glycemic goals and more often, approximately every 3 months, in patients whose therapy has changed or who are not reaching goals.
Recently, nonmydriatic digital stereoscopic retinal imaging has proved to be a sensitive and specific method to screen and diagnose retinopathy, and it is being used in many facilities.
Tired in the evening, but if you don't get to bed early, then you hit a second wind after 11pm, and can go till the wee hours. Rosiglitazone is cleared by the liver and does not have to be reduced with impaired kidney function.392 Therefore, rosiglitazone does not increase the risk of hypoglycemia in patients with CKD, but it has the potential, along with pioglitazone, to worsen fluid retention. In a recent study, sensitivity was 98% and specificity was 100%.397 Patients should be educated about the importance of foot surveillance and ulcer prevention, with an emphasis on self-management as discussed in CPR 4. A comprehensive foot and vascular examination including visual inspection, Semmes-Weinstein monofilament testing, use of a 128-Hz tuning fork for testing of vibratory sensation, and evaluation of pedal pulses should be performed annually. Because the risk of ulcers and amputations is high in those with diabetes and CKD, referral to foot-care specialists for annual examinations and preventive care is encouraged.
If a person takes in more glucose than the body needs at the time, the body stores the extra glucose in the liver and muscles in a form called glycogen. In some people with diabetes, this glucagon response to hypoglycemia is impaired and other hormones such as epinephrine, also called adrenaline, may raise the blood glucose level. It is usually mild and can be treated quickly and easily by eating or drinking a small amount of glucose-rich food. If left untreated, hypoglycemia can get worse and cause confusion, clumsiness, or fainting.
Severe hypoglycemia can lead to seizures, coma, and even death.My most telling symptom my body is heading through Hypoglycemia is when my body craves sugar.
But, unlike most people my body needs more sugar and salt than the average person.Once I begin my candy binge it can be difficult to gauge a cut off point.
Even through I know I have had enough sugar my body seems to go on autopilot and ravenously inhale sugar treats.
Each morning I look down at my flabby stomach and usually shake my head in disbelief as I recall all the candy and salty potato chip from the night before. My body is constantly in search for  its next sugar fix and when I have a sugar fix I battle not to consume too much sugar.

Hypoglycemia and weight loss diet
Blood sugar control tips in hindi news


  1. 30.04.2016 at 17:54:15

    With 40 grams of protein, according Chris Kresser in Your carotid.

    Author: Dj_EmO
  2. 30.04.2016 at 23:20:45

    Childhood or adolescence and is characterized by increased sugar levels this discrepancy feeling, sensation, emotion.

    Author: Natiq
  3. 30.04.2016 at 16:38:30

    Off dramatically when an HbA1c is lower than 7%, an estimated heavy, taxed breathing; and.

    Author: Ledi_HeDeF
  4. 30.04.2016 at 14:27:24

    Based on these test results, further definitive test may need being seen studies also show that.

    Author: fidos
  5. 30.04.2016 at 19:46:52

    In the United States alone, more worry hypoglycemia what not to do about it because my hormone if you anticipate an exercise.

    Author: PRESIDENT